Las Vegas, NV -- (SBWIRE) -- 12/11/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Tower Group International, Ltd. (NASDAQ:TWGP), Cell Therapeutics Inc (NASDAQ:CTIC), DragonWave, Inc. (USA)(NASDAQ:DRWI), Coronado Biosciences Inc (NASDAQ:CNDO)
Tower Group International, Ltd. (NASDAQ:TWGP) managed to keep its gain at 2.36% on above-normal volume of 4.92M shares. The stock settled at $3.90 after floating in a range of $3.65 to $3.93. Its latest price has reached market capitalization of $218.82 million. Its 52-week range has been $3.53 to $22.30.
For How Long TWGP will fight for Profitability? Read This Trend Analysis report
Cell Therapeutics Inc (NASDAQ:CTIC) traded down on a volume of 4.09 million, higher than its standard daily volume. Shares have dropped-4.09% to $1.77. Over the last twelve months, the stock has gained 31.11% and faced a worst price of $0.97. Cell Therapeutics, Inc. (CTI) is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic ways to treats cancer. The Company is concentrating its efforts on treatments that target blood-related cancers where there is an unmet medical need. The Company is primarily focused on commercializing PIXUVRI (pixantrone) in the European Union for multiplies relapsed or refractory aggressive non-Hodgkin lymphoma (NHL), and conducting a Phase III clinical trial of pacritinib for the treatment of myelofibrosis. PIXUVRI is a novel aza-anthracenedione derivative that is structurally related to anthracyclines and anthracenediones, but does not appear to be associated with the same level of cardiotoxic effects.
Has CTIC Found The Bottom And Ready To Gain Momentum? Find Out Here
DragonWave, Inc. (USA)(NASDAQ:DRWI) settled -2.13% lower at $1.38 on above-normal volume of 3.79M shares during the last trading day. The stock has its 12-month high at $3.74 and 52-week low price was $1.08. It traded in a range of $1.35 to $1.53 during the last trading day DragonWave Inc. (DragonWave) is in the business of developing broadband wireless backhaul and pseudowire equipment. The Company is a provider of wireless Ethernet equipment used in Internet protocol (IP) networks. DragonWave designs, develops, markets and sells carrier-grade microwave radio frequency networking equipment (referred to as links), that wirelessly transmit broadband voice, video and other data between two points. Its wireless carrier-Ethernet links, which are based on a native Ethernet platform, function as a wireless extension to an existing fiber and global optic core telecommunications network.
Will DRWI Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Coronado Biosciences Inc (NASDAQ:CNDO) was down on high volume, trading at a volume of 3.73M versus its average daily volume of 1.33 million shares. At $1.80, the stock has attained market capitalization of 61.10 million. Coronado Biosciences, Inc. is a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. The Company’s two principal pharmaceutical product candidates in clinical development include Trichuris suis ova or CNDO-201 (TSO) a biologic comprising of the microscopic eggs of the porcine whipworm, for the treatment of autoimmune diseases, such as Crohn’s disease (Crohn’s), ulcerative colitis (UC) and multiple sclerosis (MS), and CNDO-109, a compound that activates natural killer (NK) cells of the immune system to seek and destroy cancer cells, for the treatment of acute myeloid leukemia (AML). In January 2011, the Company acquired the OvaMed GmbH License.
Why Should Investors Buy CNDO After the Recent Fall? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)